Pyry A. J. Välitalo

Allometric Scaling of Clearance in Paediatric Patients: When Does the Magic of 0.75 Fade?

Elisa A. M. Calvier, Elke H. J. Krekels, Pyry A. J. Välitalo et al. · Clinical Pharmacokinetics · 2016 · 104 citations · Full text

Morbidly Obese Patients Exhibit Increased CYP2E1-Mediated Oxidation of Acetaminophen

Anne van Rongen, Pyry A. J. Välitalo, Mariska Y. M. Peeters et al. · Clinical Pharmacokinetics · 2016 · 103 citations · Full text

Prediction of human CNS pharmacokinetics using a physiologically-based pharmacokinetic modeling approach

Yumi Yamamoto, Pyry A. J. Välitalo, Yin Cheong Wong et al. · European Journal of Pharmaceutical Sciences · 2017 · 80 citations · Full text

Human Cns Pharmacokinetics, Pharmacokinetic Modeling, Neurophysiology +11

Predicting Drug Concentration‐Time Profiles in Multiple CNS Compartments Using a Comprehensive Physiologically‐Based Pharmacokinetic Model

Yumi Yamamoto, Pyry A. J. Välitalo, Dymphy Huntjens et al. · CPT Pharmacometrics & Systems Pharmacology · 2017 · 75 citations · Full text

Multiple Cns Compartments, Cns Compartments, Drug Concentration‐time Profiles +19

A Generic Multi-Compartmental CNS Distribution Model Structure for 9 Drugs Allows Prediction of Human Brain Target Site Concentrations

Yumi Yamamoto, Pyry A. J. Välitalo, Dirk‐Jan van den Berg et al. · Pharmaceutical Research · 2016 · 68 citations · Full text